Summary

  • Tilray Brands, Inc. is a leading global cannabis lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America.
  • During the period June to August 2022, the company reported net revenue of $153.21 million, which was $168.02 million during the same period of the previous year.
  • For the year ended May 31, 2022, net revenue of the company is reported $628,372 thousands, which was $513,085 thousands a year earlier.
  • Thus, reported operating loss for the two successive years are $610,401 thousands, and $132,171 thousands, respectively. However, the company generated a non-operating income of $197,671 thousands during the latest financial year, which was a loss of $184,838 thousands
  • The company has four reportable segments – Cannabis, Distribution, Beverage alcohol, and Wellness. Revenue from the segments is – 38%, 41%, 11% and 9% of the total revenue, respectively.
  • The brands of Tilray can be grossly divided into four parts – Tilray medical, adult-use brands, craft-beverage brands, Tilray wellness. Some of the Brands are – Tilray, Aphria, Broken Coast, Symbios etc.

Brief Company Overview

Tilray Brands, Inc. (NASDAQ: TLRY; TSX: TLRY) is a cannabis research company established in 2013 in Canada.1 The company received approval from Canadian health Tilray Brands Logoauthority for production and research of medicinal cannabis a year later. Users of the products of the company include doctors, patients, pharmacies, hospitals, authorities, and researchers. Tilray produce its products in three locations – Canada, Germany and Portugal, and exports to 20 countries around 5 continents of the world. The company offers about 20 brands including cannabis offerings, hemp-based foods, and craft beverages.2

Tilray Brands, Inc. is a global cannabis lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. Tilray’s mission is to be the most responsible, trusted and market leading cannabis consumer products company in the world with a portfolio of innovative, high-quality and beloved brands that address the needs of the consumers, customers and patients.3

Tilray got incorporated in the State of Delaware on January 24, 2018. The company traded publicly on NASDAQ in July 2018 at $17 and subsequently price has increased to $214 by September, 2018 and descended over a year to $29 on August, 2019. On April 30, 2021, Tilray acquired all of the issued and outstanding common shares of Aphria Inc. via a plan of arrangement.

cover photo tilray brands

Financial Analysis

Tilray Brands has four reportable segments: Cannabis business – Cultivation, production, distribution and sale of both medical and adult-use cannabis products, Distribution business – purchase and resale of pharmaceutical and wellness products, Beverage alcohol business – production, marketing and sale of beverage alcohol products, Wellness business – production, marketing and distribution of hemp-based food and other wellness products.

Q3 Results

The financial year of Tilray ends on May 31 each year, therefore, the third quarter ends on August 31. During the period June to August 2022, the company reported net revenue of $153.21 million, which was $168.02 million during the same period of the previous year. Reported gross profit is $48.61 million and $50.09 million for the two periods, respectively. After incurring $69.79 million and $120.32 million of operating expenditures, the company reported $21.18 million and $69.37 million in net operating loss for third quarter of 2022 and that of 2021, respectively. Net loss of the company stands at $65.79 million in the third quarter of 2022 and $34.60 million a year earlier. Earnings per share (EPS) of the company in Q3’22 is negative $0.13, which was negative $0.08 in Q3’21.

Analysis of the Past Year

Income Statement

For the year ended May 31, 2022, net revenue of the company is reported $628,372 thousands, which was $513,085 thousands a year earlier. Gross profit for the outgoing financial year is $116,817 thousands and $123,182 thousands for the previous. Reported operating expenses of the company for the year 2022 is $727,218 thousands, which was $255,353 thousands a year earlier. The operating expenditure during the outgoing year is way higher due to increased amortization cost and impairments during the year. During the year ended May 31, 2022, as a result of delays in product registrations in Latin America and changes in market opportunities, causing a shift in our strategic priorities, management recorded a non-cash impairment of $110,033 thousands of licences, permits and applications and $85,471 thousands of intellectual property, trademarks, knowhow & brands, representing all of the intangible asset values related to those entities, and discounted cash flows. Also, the Company recognized impairment charges of $182,736 thousands in cannabis goodwill recorded in impairment. These impairment charges were a related to changes in market opportunities, causing a shift in the strategic priorities of the company, and market conditions inclusive of higher rates of borrowing and lower foreign exchange rates.

Thus, reported operating loss for the two successive years are $610,401 thousands, and $132,171 thousands, respectively. However, the company generated a non-operating income of $197,671 thousands during the latest financial year, which was a loss of $184,838 thousands. Thus, the big difference between the operating losses has been smoothened out and the company reported $434,132 thousands and $336,014 thousands in net loss, respectively.

Earnings per share (EPS) of the company is reported $0.90 in 2022 and $1.25 in 2021. Weighted average number of shares outstanding during these two years are 481,219,130 and 269,549,852, respectively.

Segment Report

The company has four reportable segments – Cannabis, Distribution, Beverage alcohol, and Wellness. Revenue from the segments is – 38%, 41%, 11% and 9% of the total revenue, respectively.

Cannabis revenues come from primarily four sub-segments – medical cannabis products, adult-use cannabis products, wholesale cannabis products, and international cannabis products. Revenue from Canadian medical cannabis products increased 20% to $30.6 million for the year ended May 31, 2022, compared to revenue of $25.5 million for the year ended May 31, 2021. This increase in revenue from medical cannabis products is primarily driven by the contributions of legacy Tilray’s medical cannabis business resulting from the business combination on April 30, 2021. The increase is also due to new innovative product launches, including the new brand Symbios launched earlier in the year, to address unmet medical needs and to provide patients with more choices in managing their health conditions with medical products. This increase was partially offset by the limitations caused by the COVID-19 pandemic from patients unable or unwilling to see a doctor as well as increased competition from the adult-rec and the price compression therein.

During the year ended, May 31, 2022, gross revenue from Canadian adult-use cannabis product has decreased 6% to $209.5 million compared to revenue of $222.9 million for the prior year. The decline, according to company reports, is due to several reasons including the shocks of Covid-19 pandemic, price competition due to new entrants in the market, and the decline of Canadian dollar compared to the period ended on May 31, 2021.

Revenue from Distribution operations for the year ended May 31, 2022 was $259.7 million as compared to $277.3 million in the prior year, representing a decrease of 6% on a year over year basis. The decrease in distribution revenue for the year ended as compared to prior year was primarily the result of the decrease in the value of the Euro compared to the US dollar totaling a $28.3 million reduction for the year ended May 31, 2022 compared to May 31, 2021 in the company’s CC Pharma business. On a constant currency basis, distribution revenue would have increased by 4% or $10.7 million from the prior year. Revenue for the year ending May 31, 2022, was also impacted by heavy flooding impacted CC Pharma which forced a business closure for approximately five days leading to a decrease in net revenue in the period of almost $5.0 million.

Revenue from Tilray’s Beverage Alcohol operations increased to $71.5 million for the year ended May 31, 2022, compared to revenue of $28.6 million in the year ended May 31, 2021. The increase is largely driven by the fact that the company entered the beverage alcohol space on November 25, 2020, through the acquisition of SweetWater, and thus the prior year comparative only includes 6 months of operations. Further enhancing this increase, the company also acquired Breckenridge distillery on December 7, 2021, which partially contributed to the year over year increase. Sweetwater revenue increased in the year ended May 31, 2022, as Tilray began operating their new brewing facility in Colorado and opened a new taproom at the Denver International Airport in connection with their strategic expansion initiative. In addition, Tilray released an extensive new line of innovative products, including seltzers, as well as a new beer offering developed in collaboration with their Canadian cannabis Broken Coast brand and anew vodka soda offering developed in collaboration with their Canadian cannabis Riff brand as Tilray continues to strengthen its strategic position in the U.S. by expanding its presence through acquisitions and collaboration with other Tilray cannabis brands.

Wellness revenue of Tilray consists of $59.6 million from Manitoba Harvest, for the year ended May 31, 2022, which is compared to $5.8 million for the prior year ended of May 31, 2021. Manitoba Harvest was part of the assets acquired in the Arrangement on April 30, 2021. As a result, the prior period only included one month of operations and thus the large increase in revenue year over year is a result the realization of a full year of operations in the current year.

Adjusted gross profit from Cannabis, Distribution, Beverage alcohol, and Wellness segment of the company is – $102,188, $24,016, $41,673, and $18,154.

Balance sheet

Reported current assets for the company at the end of the latest financial year is $803,503 thousand, which was $883,609 thousands in financial year 2021. Among the long-term assets, the company reported intangible assets, and goodwill less than the preceding financial year. The company incurred impairment expense of $378.2 million on goodwill and intangible assets during the year ended May 31, 2022.4 Thus, the total assets of the company has lessened than the previous year to $5,448,694 from $6,025,362 thousands. Total current liabilities of the company is reported $280,342 thousand, down from $401,241 thousand. The company has reported accumulated deficit of $962,851 thousand at the end of the fiscal year of 2022. However, the company has covered the increased losses by raising additional paid-in capital. Additional paid-in capital has increased from $4.79 billion to $5.38 billion.

Expansions

Tilray Brands, Inc. continue to focus on expanding their product offerings to accommodate the changes in adult-use customers, during the first quarter of fiscal 2022, the company completed their first shipments to Nunavut, Canada. In the second quarter of 2022, it has expanded the terms of distribution partnership with Rose LifeScience, which now represents the entire Tilray portfolio in Quebec.5 In addition, Tilray expanded partnership with Great North Distributors, Inc. to represent the entire Tilray portfolio and cover all of Canada, except for Quebec, using its established network.

Tilray also completed the strategic alliance with HEXO on July 12, 2022. The company plans to leverage this relationship to identify production efficiencies and generate cost savings. The alliance will also allow Tilray to enter into new product categories by utilizing the manufacturing capabilities of both parties.

Business Overview

Tilray is a global leader in cannabis research, cultivation, processing and distribution. The company aspires to lead, legitimize and define the future of the cannabis industry by building the world’s most trusted cannabis and hemp facilities. A proud pioneer, Tilray is the first GMP-certified medical cannabis producer to supply cannabis flower and extract products to tens of thousands of patients, physicians, pharmacies, hospitals, governments and researchers on five continents.6

Tilray cultivates a wide range of strains to meet patient needs including indicas, sativas, hybrids, and CBD-rich varieties. Medical cannabis is available in two primary forms: extracts and dried flower. Each can be administered or consumed via a variety of methods.

In the production process, the company starts with a mother plant and makes clones of it. From the clones, the starter plants are established and vegetated from about two weeks. Another 8-12 weeks are required for plucking the flower of the plants. The flowers are dried, secured, and trimmed as per requirement. The company then extract its necessary elements, analyse and package them into its final product. The products are then boxed and shipped. The company controls the whole process from beginning to the ends and outsources no part of its production cycle.

Brands

The brands of Tilray can be grossly divided into four parts – Tilray medical, adult-use brands, craft-beverage brands, Tilray wellness. Some of the Brands are stated in detail and some are listed here.

Tilray Medical: Tilray

Tilray is the global leader in the advancement of cannabinoid-based medicine, with a keen focus on providing research-backed medical cannabis products to physicians, pharmacies, and patients, around the world. Tilray is dedicated to progressing the science, safety, and efficacy of medical cannabis.

tilray brands Tilray

Tilray Medical: Aphria

Aphria is a Licensed Producer of medical cannabis products.

Aphria Tilray brands

Tilray Medical: Broken Coast

According to company website, Broken Coast is respected by growers across the industry for their mastery of cultivation practices – and symbolizes the respect for the delicate art and intricate science of harvesting the cannabis plant. They produce craft cannabis of exceptional quality on the shores of the Salish Sea, with a mission to provide the highest-grade products to the discerning medical cannabis patient. Broken Coast flower is indoor-grown in small batches in their custom-made cultivation facility, which allows for optimal conditions for every strain.

Broken coast Tilray brands

Tilray Medical: Symbios

According to company website, Symbios was designed with quality, care, and affordability in mind, to help support patients on their medical and wellness journey. Symbios represents the connection between plants and humans and the profound benefits that can be realized when these two organisms come together in perfect harmony.

symbios Tilray brands

Adult-use Brands

In this line of products, the company has – Good Supply, Solei, RIFF, Canaca, Chowie Wowie, and The Batch.7

Craft-Beverage Brands

In this category, the company has these products – SweetWater Brewery, Breckenridge Distillery, Green Flash Brewing Co., Alpine Beer Company, and Montauk Brewing Company.

Recent Developments 

  • Tilray partnered with Charlotte’s Web – another cannabis company, in November, 2022.8
  • Tilray announced its acquisition of Montauk Brewing – the #1 craft brewer in Metro New York, on November, 2022.9
  1. ^ https://tilraymedical.eu.com/about-tilray/
  2. ^ https://ir.tilray.com/
  3. ^ https://www.tilray.com/tilraynews-master/2022/11/9/potently-canadian-cannabis-brand-canaca-launches-new-products-and-feeltheboost-campaign
  4. ^ For further info on impairment see 10-K Filing 2022, p.59
  5. ^ See 10-K Filing 2022, p.53 
  6. ^ https://www.tilray.com/
  7. ^ Refer to https://www.tilray.com/adultuse-brands
  8. ^ https://www.fool.com/investing/2022/11/10/tilray-brands-is-partnering-with-another-us-cannab/
  9. ^ https://www.globenewswire.com/news-release/2022/11/07/2549865/0/en/Tilray-Brands-Acquires-Montauk-Brewing-Company.html
Tags:
Created by MD. TOUHIDUL ISLAM on 2022/10/16 01:20
     

Become a Contributor

If you follow a company closely and would like to share your knowledge, we would love your contributions. Register Now and start editing!

Tag Cloud

  1. AU:BHP
  2. AU:DTL
  3. AU:PNC
  4. AU:SSR
  5. BD:ACI
  6. BD:AMCL.PRAN
  7. BD:BATBC
  8. BD:BERGERPBL
  9. BD:BEXIMCO
  10. BD:BRACBANK
  11. BD:BSRMLTD
  12. BD:GP
  13. BD:KOHINOOR
  14. BD:LANKABAFIN
  15. BD:MARICO
  16. BD:PREMIERCEM
  17. BD:RBBL
  18. BD:RENATA
  19. BD:ROBI
  20. BD:SINGERBD
  21. BD:SQURPHARMA
  22. BD:WALTONHIL
  23. Brazil
  24. CA:ABX
  25. CA:AC
  26. CA:AEM
  27. CA:AFI
  28. CA:AGI
  29. CA:AQN
  30. CA:BAM.A
  31. CA:BCE
  32. CA:BHC
  33. CA:BLDP
  34. CA:BMO
  35. CA:BNS
  36. CA:BTO
  37. CA:CCO
  38. CA:CM
  39. CA:CNQ
  40. CA:CNR.TO
  41. CA:CP
  42. CA:CSU
  43. CA:CU
  44. CA:CVE
  45. CA:EMA
  46. CA:ENB
  47. CA:FFH
  48. CA:FM
  49. CA:FSV
  50. CA:FTS
  51. CA:GFL
  52. CA:GIB
  53. CA:GWO
  54. CA:H
  55. CA:IFC
  56. CA:IMO
  57. CA:K
  58. CA:LULU
  59. CA:MFC
  60. CA:MG
  61. CA:MRU
  62. CA:MX
  63. CA:NA
  64. CA:NG
  65. CA:NTR
  66. CA:OTEX
  67. CA:PASS
  68. CA:POW
  69. CA:PPL
  70. CA:PVG
  71. CA:QSR
  72. CA:RBA
  73. CA:RCI.A
  74. CA:RY
  75. CA:SHOP
  76. CA:SJR.B
  77. CA:SLF
  78. CA:SSRM
  79. CA:STN
  80. CA:SU
  81. CA:T
  82. CA:TA
  83. CA:TARD
  84. CA:TD
  85. CA:TECK
  86. CA:TFII
  87. CA:TRI
  88. CA:TRP
  89. CA:WEED
  90. CA:WN
  91. CA:WPM
  92. CA:WSP
  93. CA:X
  94. CA:YRI
  95. Canada
  96. CH:ALSN
  97. CH:NESN
  98. CIPLA
  99. DE:TIMA
  100. EU:CCAP
  101. EU:HHFA
  102. FR:CEN
  103. FR:HCO
  104. GB:0HMI
  105. GB:0L85
  106. GB:0Q1S
  107. GB:0QZD
  108. GB:AAL
  109. GB:ABDN
  110. GB:ABF
  111. GB:ADM
  112. GB:AHT
  113. GB:ANTO
  114. GB:AUTO
  115. GB:AUY
  116. GB:AV
  117. GB:AVST
  118. GB:AVV
  119. GB:AZN
  120. GB:BA
  121. GB:BARC
  122. GB:BATS
  123. GB:BDEV
  124. GB:BHP
  125. GB:BME
  126. GB:BP
  127. GB:CCH
  128. GB:CPG
  129. GB:CTO
  130. GB:DARK
  131. GB:DGE
  132. GB:FERG
  133. GB:GLEN
  134. GB:HL
  135. GB:HSBA
  136. GB:IHG
  137. GB:III
  138. GB:IMB
  139. GB:INCH
  140. GB:NWG
  141. GB:NXR
  142. GB:OCDO
  143. GB:REL
  144. GB:RIO
  145. GB:RKT
  146. GB:SGE
  147. GB:SGRO
  148. GB:SKG
  149. GB:SMIN
  150. GB:SN
  151. GB:STAN
  152. GB:STJ
  153. GB:WPP
  154. Great Britain
  155. HK:0995
  156. HK:1052
  157. HK:107
  158. HK:189
  159. HK:548
  160. HK:819
  161. HK:995
  162. IN:3MINDIA
  163. IN:ADANITRANS
  164. IN:BHARATFORG
  165. IN:CIPLA
  166. IN:CROMPTON
  167. IN:GODREJIND
  168. IN:HDFCAMC
  169. IN:IDEA
  170. IN:INDUSTOWER
  171. IN:LICI
  172. IN:LUPIN
  173. IN:LUPINE
  174. IN:MFSL
  175. IN:MOFSL
  176. IN:MOTHERSUMI
  177. IN:MUTHOOTFIN
  178. IN:NATCOPHARM
  179. IN:NATIONALUM
  180. IN:NBCC
  181. IN:NESTLEIND
  182. IN:NIACL
  183. IN:NMDC
  184. IN:OBEROIRLTY
  185. IN:OFSS
  186. IN:PAGEIND
  187. IN:PAYTM
  188. IN:PEL
  189. IN:PETRONET
  190. IN:PFIZER
  191. IN:PGHH
  192. IN:PIDILITIND
  193. IN:PIIND
  194. IN:PNB
  195. IN:PNBHOUSING
  196. IN:POWERGRID
  197. IN:QUESS
  198. IN:RAMCOCEM
  199. IN:RELAXO
  200. IN:SAIL
  201. IN:SANOFI
  202. IN:SBILIFE
  203. IN:SIEMENS
  204. IN:SRF
  205. IN:SUPREMEIND
  206. IN:TATAPOWER
  207. IN:TECHM
  208. IN:TITAN
  209. IN:TORNTPHARM
  210. IN:TORNTPOWER
  211. IN:TRENT
  212. IN:TVSMOTOR
  213. IN:UBL
  214. IN:ULTRACEMCO
  215. IN:UNIONBANK
  216. IN:UPL
  217. IN:VBL
  218. IN:WHIRLPOOL
  219. IN:ZEEL
  220. Ireland
  221. JP:1070
  222. JP:2654
  223. JP:4220
  224. JP:4734
  225. JP:6916
  226. SG:BCY
  227. SG:F13
  228. UK:IHG
  229. US:AABA
  230. US:AAOI
  231. US:AAPL
  232. US:AAUKF
  233. US:ABCL
  234. US:ABEO
  235. US:ABUS
  236. US:ACAD
  237. US:ACAN
  238. US:ACBFF
  239. US:ACDVF
  240. US:ACHN
  241. US:ACIA
  242. US:ACRX
  243. US:ADAP
  244. US:ADMP
  245. US:ADMS
  246. US:ADXS
  247. US:AEM
  248. US:AEZS
  249. US:AFMD
  250. US:AGEN
  251. US:AGI
  252. US:AGRX
  253. US:AGTK
  254. US:AKAO
  255. US:ALDR
  256. US:ALIM
  257. US:ALQA
  258. US:AMC
  259. US:AMD
  260. US:AMDA
  261. US:AMIGF
  262. US:AMMJ
  263. US:AMN
  264. US:AMPE
  265. US:AMRN
  266. US:AMRS
  267. US:AMZN
  268. US:ANCUF
  269. US:ANFGF
  270. US:ANLDF
  271. US:ANTH
  272. US:ANY
  273. US:APHQF
  274. US:AQMS
  275. US:AQN
  276. US:AQSZF
  277. US:ARDX
  278. US:ARGS
  279. US:ARLZ
  280. US:ARNA
  281. US:ARRY
  282. US:ARWR
  283. US:ASBFF
  284. US:ASHTF
  285. US:ATDRY
  286. US:ATER
  287. US:ATHX
  288. US:ATNM
  289. US:ATOS
  290. US:ATRS
  291. US:AUPH
  292. US:AUY
  293. US:AVASF
  294. US:AVEO
  295. US:AVEVF
  296. US:AVGR
  297. US:AVIR
  298. US:AVP
  299. US:AVVIY
  300. US:AVXL
  301. US:AXON
  302. US:AXSM
  303. US:AZN
  304. US:BABA
  305. US:BAC
  306. US:BAESF
  307. US:BAM
  308. US:BBAY
  309. US:BBIG
  310. US:BBRY
  311. US:BCE
  312. US:BCOR
  313. US:BCS
  314. US:BHP
  315. US:BIOA
  316. US:BIOC
  317. US:BLCM
  318. US:BLDP
  319. US:BLEVF
  320. US:BLOZF
  321. US:BLPH
  322. US:BLRX
  323. US:BMO
  324. US:BMRPF
  325. US:BNS
  326. US:BP
  327. US:BPMX
  328. US:BSTG
  329. US:BTDPF
  330. US:BTE
  331. US:BTG
  332. US:BTI
  333. US:BW
  334. US:BZUN
  335. US:CALA
  336. US:CANN
  337. US:CAPR
  338. US:CARA
  339. US:CASC
  340. US:CATB
  341. US:CBDS
  342. US:CCJ
  343. US:CEI
  344. US:CERC
  345. US:CERU
  346. US:CHK
  347. US:CIE
  348. US:CLDX
  349. US:CLF
  350. US:CLOV
  351. US:CLSN
  352. US:CLVS
  353. US:CM
  354. US:CMPGF
  355. US:CNAB
  356. US:CNAT
  357. US:CNBX
  358. US:CNI
  359. US:CNQ
  360. US:CNSWF
  361. US:CORT
  362. US:CP
  363. US:CPRX
  364. US:CRBP
  365. US:CRIS
  366. US:CRMD
  367. US:CTRV
  368. US:CU
  369. US:CUR
  370. US:CVE
  371. US:CVSI
  372. US:CYCC
  373. US:CYTR
  374. US:CYTX
  375. US:DCTH
  376. US:DEPO
  377. US:DGEAF
  378. US:DMPI
  379. US:DRKTF
  380. US:DRYS
  381. US:DVAX
  382. US:DXTR
  383. US:DYLLF
  384. US:EARS
  385. US:ECYT
  386. US:EDIT
  387. US:EGLT
  388. US:EKSO
  389. US:ELVT
  390. US:ENB
  391. US:ENDP
  392. US:ENRT
  393. US:ETRM
  394. US:EVC
  395. US:EXEL
  396. US:FATE
  397. US:FB
  398. US:FERG
  399. US:FINL
  400. US:FIT
  401. US:FLXN
  402. US:FOLD
  403. US:FQVLF
  404. US:FRFHF
  405. US:FSV
  406. US:FTR
  407. US:FTS
  408. US:FVE
  409. US:FWDG
  410. US:GALE
  411. US:GALT
  412. US:GBHPF
  413. US:GBT
  414. US:GERN
  415. US:GFL
  416. US:GIB
  417. US:GILD
  418. US:GLDFF
  419. US:GLEN
  420. US:GLYC
  421. US:GME
  422. US:GNCA
  423. US:GNMX
  424. US:GOLD
  425. US:GPRO
  426. US:GSAT
  427. US:GVXXF
  428. US:GWLIFU
  429. US:HLTH
  430. US:HMNY
  431. US:HRGLF
  432. US:HRNNF
  433. US:HRTX
  434. US:HSBA
  435. US:HTGM
  436. US:HTZ
  437. US:HUSA
  438. US:ICPT
  439. US:IDRA
  440. US:IDXG
  441. US:IFCZF
  442. US:IHG
  443. US:IMBBF
  444. US:IMGN
  445. US:IMMU
  446. US:IMNP
  447. US:IMO
  448. US:IMUC
  449. US:INFI
  450. US:INPX
  451. US:INSM
  452. US:INTC
  453. US:INVA
  454. US:ITEK
  455. US:IVITF
  456. US:JD
  457. US:JOBS
  458. US:JVA
  459. US:KAYS
  460. US:KEM
  461. US:KERX
  462. US:KGC
  463. US:KTOS
  464. US:KTOV
  465. US:LKM
  466. US:LODE
  467. US:LPCN
  468. US:LULU
  469. US:LWLG
  470. US:LXRP
  471. US:MACK
  472. US:MARA
  473. US:MBOT
  474. US:MBRX
  475. US:MDCL
  476. US:MDCO
  477. US:MEET
  478. US:MEIP
  479. US:MEOH
  480. US:MFC
  481. US:MGA
  482. US:MGWFF
  483. US:MNKD
  484. US:MOMO
  485. US:MQPXF
  486. US:MRNS
  487. US:MRTX
  488. US:MSFT
  489. US:MTRAFU
  490. US:MU
  491. US:MVIS
  492. US:MZOR
  493. US:NAK
  494. US:NBEV
  495. US:NBRV
  496. US:NEOS
  497. US:NG
  498. US:NH
  499. US:NLNK
  500. US:NMUS
  501. US:NTIOF
  502. US:NTNX
  503. US:NTR
  504. US:NVAX
  505. US:NVCN
  506. US:NVDA
  507. US:NVRO
  508. US:NWBO
  509. US:NWG
  510. US:NXTTF
  511. US:NYMX
  512. US:OCDGF
  513. US:OCLR
  514. US:OCUL
  515. US:OGRMF
  516. US:OMER
  517. US:ONCS
  518. US:ONTX
  519. US:ONVO
  520. US:OPGN
  521. US:OPHT
  522. US:OPK
  523. US:OPTT
  524. US:OTEX
  525. US:OTIC
  526. US:P
  527. US:PANXF
  528. US:PARA
  529. US:PASS
  530. US:PBA
  531. US:PBR
  532. US:PBYI
  533. US:PETS
  534. US:PETX
  535. US:PGNX
  536. US:PHOT
  537. US:PIRS
  538. US:PLSE
  539. US:PLUG
  540. US:PLX
  541. US:PRTO
  542. US:PSDV
  543. US:PTI
  544. US:PTN
  545. US:PTON
  546. US:PTX
  547. US:PUFXF
  548. US:PULM
  549. US:PVG
  550. US:QRSRF
  551. US:QSR
  552. US:RAD
  553. US:RBA
  554. US:RBGPF
  555. US:RCI
  556. US:RCKT
  557. US:RDHL
  558. US:RDUS
  559. US:RELX
  560. US:REPH
  561. US:RGLS
  562. US:RIGL
  563. US:RIO
  564. US:RNN
  565. US:RNVA
  566. US:ROX
  567. US:RSSFF
  568. US:RTTR
  569. US:RY
  570. US:SCYX
  571. US:SDRL
  572. US:SEGXF
  573. US:SENS
  574. US:SESN
  575. US:SGBY
  576. US:SGGEF
  577. US:SGMO
  578. US:SGYP
  579. US:SHMP
  580. US:SHOP
  581. US:SJR
  582. US:SKLN
  583. US:SLF
  584. US:SLFPF
  585. US:SMFTF
  586. US:SMGKF
  587. US:SNAP
  588. US:SNN
  589. US:SPHS
  590. US:SPLIF
  591. US:SPRWF
  592. US:SQ
  593. US:SRNA
  594. US:SRNE
  595. US:SRRA
  596. US:SSRM
  597. US:STJPF
  598. US:STLY
  599. US:STML
  600. US:STMP
  601. US:STN
  602. US:STRRF
  603. US:SU
  604. US:SWN
  605. US:SYN
  606. US:TAC
  607. US:TBQBF
  608. US:TD
  609. US:TECK
  610. US:TENX
  611. US:TEVA
  612. US:TFII
  613. US:TGOPF
  614. US:TGTX
  615. US:THCBF
  616. US:TK
  617. US:TMXXF
  618. US:TNDM
  619. US:TOP
  620. US:TRI
  621. US:TROV
  622. US:TRP
  623. US:TRTC
  624. US:TRVN
  625. US:TRXC
  626. US:TSG
  627. US:TSLA
  628. US:TTM
  629. US:TTNP
  630. US:TTNQY
  631. US:TU
  632. US:TVTY
  633. US:TWTR
  634. US:TXMD
  635. US:UBQU
  636. US:UNXL
  637. US:VAPE
  638. US:VBLT
  639. US:VCEL
  640. US:VDQSF
  641. US:VPCO
  642. US:VSTM
  643. US:VXRT
  644. US:VZ
  645. US:WIT
  646. US:WLDFF
  647. US:WLL
  648. US:WMIH
  649. US:WMT
  650. US:WPM
  651. US:WPP
  652. US:WSPOF
  653. US:XGTI
  654. US:XON
  655. US:XTNT
  656. US:XXII
  657. US:ZGNX
  658. US:ZSAN
  659. US:ZYNE
This site is funded and maintained by Fintel.io